Familial Mediterranean fever (FMF) is an inherited disorder characteri
zed by recurrent self-limiting attacks of joint, chest and abdominal p
ain associated with fever. The most serious complication in FMF is the
development of amyloidosis, which usually leads to death from renal f
ailure within a year. The use of colchicine has dramatically reduced t
his complication. We describe a 56-yr-old female patient with FMF in w
hom the arthropathy became the dominant clinical feature, resulting in
the development of an erosive large and small joint arthritis during
the course of tile disease. The patient was treated with colchicine, b
ut despite this, later developed amyloidosis confirmed on rectal biops
y. and chlorambucil was added to her treatment. For 10 yr, she also su
ffered intermittent abdominal pain and had terminal ileal changes sugg
estive of Crohn's disease. However, she was found to have ischaemic co
litis at post mortem secondary to amyloidosis. Ischaemic bowel disease
is an extremely unusual event in FMF. Other factors which may have co
ntributed to the terminal ischaemia in this patient include anaemia se
condary to blood loss and a drug-induced myelodysplasia, as well as hy
potension during the final septicaemic illness. Clinicians should cons
ider an ischaemic colitis as a possible differential diagnosis of abdo
minal pain in patients with FMF even in the absence of other clinical
evidence of systemic amyloidosis.